Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

NCT00639301 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00639301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00639301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
March 11, 2008
Completion date
March 31, 2027
Enrollment
473 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma